MedAlerts Home
  Read the MedAlerts Blog Subscribe to the MedAlerts Blog 

This is VAERS ID 351587

Case Details

VAERS ID:351587 (history)  Vaccinated:2009-03-23
Age:17.0  Onset:2009-04-10, Days after vaccination: 18
Gender:Female  Submitted:2009-07-16, Days after onset: 97
Location:Foreign  Entered:2009-07-16
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0583179A
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALS  UNLA
Administered by: Other     Purchased by: Other
Symptoms: Drug exposure during pregnancy, Pregnancy on oral contraceptive
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Normal pregnancy conditions and outcomes (narrow)
Write-up: This case was reported by a foreign regulatory authority (# 2009-02622) and described the occurrence of pregnancy on oral contraceptive in a 17-year-old female subject who was vaccinated with PRIORIX (GlaxoSmithKline), ENGERIX B adult and GARDASIL (non-GSK). Since April 2008, the subject was under YASMIN without forgetting to take the pill, without co-medication or episode of diarrhea or vomiting. On 23 March 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). On 27 March 2009, the subject had her last menstruation. On 30 March 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 10 April 2009 (estimated date of conception for a regular cycle), the subject was found to be pregnant. On 28 May 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 8 June 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). The regulatory authority reported that the events were clinically significant (or requiring intervention). The regulatory authority reported that the events were possibly related to vaccination with PRIORIX, ENGERIX B adult and GARDASIL and to YASMIN.

New Search

Link To This Search Result:
http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=351587


Copyright © 2014 National Vaccine Information Center. All rights reserved.
407-H Church Street, Vienna, Virginia 22180